Is EMVITAL FDA-cleared?
Yes. EMVITAL is marketed by BTL Industries as an FDA-cleared Class II medical device. It is intended to provide topical heating using energy in the visible and infrared spectrum for the temporary relief of muscle and joint pain and stiffness, minor arthritis pain, or muscle spasm; the temporary increase in local blood circulation; and the temporary relaxation of muscle.
What is the specific 510(k) number for EMVITAL?
As of August 2026, a standalone 510(k) summary publicly indexed under the exact trade name “EMVITAL” is not readily available in open FDA database searches. The device operates under BTL’s cleared infrared/laser heating technology platform (associated with models such as BTL-043).
Is EMVITAL a Class II medical device?
Yes.
What technology does the FDA-cleared EMVITAL device use?
EMVITAL uses a 1064 nm near-infrared laser combined with proprietary TriHIL technology that integrates an ultrasonic sensor, an infrared thermal camera, and dynamic laser emission patterns for controlled, hands-free tissue heating.